RecruitingPhase 4NCT03821857

Sex-Specific Effects of Endocrine Disruption on Aging and Alzheimer's Disease


Sponsor

Mayo Clinic

Enrollment

614 participants

Start Date

Jun 27, 2019

Study Type

INTERVENTIONAL

Conditions

Summary

The researchers are trying to determine whether ovarian hormones are associated with aging processes and with the risk of developing Alzheimer's disease in women.


Eligibility

Sex: FEMALEMin Age: 60 Years

Plain Language Summary

Simplified for easier understanding

This study is examining how exposure to hormone-disrupting chemicals (substances in the environment that interfere with the body's hormones) might affect the risk of developing Alzheimer's disease differently in women compared to men, using brain imaging to track changes over time. **You may be eligible if...** - You are a woman aged 60 or older - You previously participated in this research study - It has been more than 6 months since you finished chemotherapy or had major surgery requiring general anesthesia - You are willing and able to give informed consent - (For the Jacksonville site) You identify as African American **You may NOT be eligible if...** - You cannot read or speak English - You are in hospice care - You are claustrophobic (especially for MRI and PET scans) - You have a heart condition called QT prolongation (if tau brain imaging is required) Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DRUG18-F-Flortaucipir

Radioligands for PET imaging of beta-amyloid and neurofibrillary tangle tau pathology


Locations(2)

Mayo Clinic

Jacksonville, Florida, United States

Mayo Clinic

Rochester, Minnesota, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT03821857


Related Trials